Friday, 5 November
2:00 PM – 4:00 PM CEST - Please register here in advance to join the webinar on ZOOM
The event will be live-streamed on our social media channels and on the video tile below
- Marina Davidashvili, Lead International Advocacy and Partnerships, European Parliamentary Forum for Sexual & Reproductive Rights (EPF, EU-Brussels)
- Prof. Mgr. Miloš Jeseňák, M.D., PhD., MBA, Dott.Ric., MHA., Department of Pediatrics, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, University Teaching Hospital in Martin (Slovakia)
- Peter Baker, Consultant, European Cancer Organisation's HPV Action Network (EU) - details about the UK gender-neutral vaccination campaign and ECO’s current effort in HPV vaccination within EU (EU/UK)
- Dr. Zoltán Novák, Head of Gynecological Surgery Department of the National Institute of Oncology – Experience in managing HPV vaccination from Hungary (Hungary/UK)
- Prof. Joakim Dillner, Director of Research & Development, Medical Diagnostics at Karolinska Institutet (Sweden)
- Sibilia Quilici, Executive Director, Vaccines Europe, EFPIA (Brussels)
- Assoc. Prof. PhDr. Kállayová Daniela, PhD., MPH, Ministry of Health-Department of Public Health, Screening & Prevention (Slovakia)
Moderator: Miroslawa Sawiris, Senior Research Fellow at GLOBSEC
HPV Vaccination is highlighted as one of the most prominent gaps in current cancer care and prevention in Europe. CEE countries lag in prevention and bear the burden of cervical cancer incidence and mortality. The vaccination rates vary even in Western Europe from less than 50% in France to more than 70% in Norway, Sweden or Spain. Looking at the CEE region countries, PL and RS are missing National Immunization Program for HPV (to be introduced in 2021), VCR for girls in BG reaches less than 5%, in SK 15%, in HR 50%, CZ and SI get on 60%, only HU is getting close to the target with 80% VCR in girls.
Europe’s Beating Cancer Plan will support EU countries efforts to extend routine vaccination against human papillomaviruses of girls and boys – in order to eliminate cervical cancer and other cancers caused by HPV. The objective is to vaccinate at least 90% of the EU target population of girls and to significantly increase the vaccination of boys by 2030.
Topical angles for webinar discussion:
- What needs to be done by member states to ensure efficient implementation of the EU Beating Cancer strategy & WHO global strategy to eliminate cervical cancer?
- Are the milestones set out by WHO & EC realistic to be achieved in CEE? What are the steps to get there (90% girls vaccinated, 70% women screened, 90% women treated)?
- With dedicated funds under the EU4Health programme and other funding instruments, Europe’s Beating Cancer Plan will support Member States’ efforts to extend routine vaccination against human papillomaviruses of girls and boys – in order to eliminate cervical cancer and other cancers caused by human papillomaviruses. The objective is to vaccinate at least 90% of the EU target population of girls and to significantly increase the vaccination of boys by 2030. Member States will play a critical role in meeting this target. How can Member States best leverage EU’s support to achieve the set objective?
- Maximizing cross-border collaboration and best practice exchange to effectively reduce the existing gap in access to GNV HPV vaccination and screening
- The European Cancer Organisation’s HPV Action Network has called for the establishment of an HPV Vaccine Tracker. How can this monitoring system help in progressing towards meeting the Beating Cancer Plan’s goal of eliminating the cancers caused by HPV?
- How can the infrastructure of covid vaccination centres be leveraged for other immunization programs including HPV vaccination?